Trial Details
AuthorisedBasic Information
| Clinical ID | c3363 |
|---|---|
| Identifier | EUCTR2005-005414-20-IT |
| Trial Title | Randomized controlled double-blind Vs. placebo multicentre study on the safety and effectiveness of thalidomide in the treatment of refractory Crohn s disease and ulcerative colitis. - Thalidomide and IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease Crohn Disease, Ulcerative Colitis MedDRA version: 6.1_Level: PT_Classification code 10021972_ |
| Interventions | Trade Name: Thalidomide Pharmion Pharmaceutical Form: Capsule, hard INN or Proposed INN: Thalidomide Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- Pharmaceutical form of the placebo: Capsule, hard Route of administration of the placebo: Oral use |
Participant Information
| Sponsor | ISTITUTO PER L INFANZIA BURLO GAROFOLO |
|---|---|
| City | - |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |